TY - JOUR
T1 - Hepatocarcinoma y trasplante hepático en Perú
T2 - resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud
AU - Mantilla Cruzatti, Omar
AU - Chaman Ortiz, José Carlos
AU - Rondon Leyva, Carlos Felix
AU - Padilla Machaca, Martin
AU - Rivera Romani, José
AU - Cardenas Ramirez, Bertha
N1 - Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.
AB - Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.
UR - http://www.scopus.com/inward/record.url?scp=85058593835&partnerID=8YFLogxK
M3 - Artículo
C2 - 30540726
AN - SCOPUS:85058593835
SN - 1022-5129
VL - 38
SP - 234
EP - 241
JO - Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
JF - Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
IS - 3
ER -